Cargando…
Immunocompromised patients have been neglected in COVID-19 trials: a call for action
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130310/ https://www.ncbi.nlm.nih.gov/pubmed/35623577 http://dx.doi.org/10.1016/j.cmi.2022.05.005 |
| _version_ | 1784712960909770752 |
|---|---|
| author | Trøseid, Marius Hentzien, Maxime Ader, Florence Cardoso, Sandra Wagner Arribas, Jose R. Molina, Jean-Michel Mueller, Nicolas Hites, Maya Bonnet, Fabrice Manuel, Oriol Costagliola, Dominique Grinsztejn, Beatriz Olsen, Inge Christoffer Yazdapanah, Yazdan Calmy, Alexandra |
| author_facet | Trøseid, Marius Hentzien, Maxime Ader, Florence Cardoso, Sandra Wagner Arribas, Jose R. Molina, Jean-Michel Mueller, Nicolas Hites, Maya Bonnet, Fabrice Manuel, Oriol Costagliola, Dominique Grinsztejn, Beatriz Olsen, Inge Christoffer Yazdapanah, Yazdan Calmy, Alexandra |
| author_sort | Trøseid, Marius |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9130310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91303102022-05-25 Immunocompromised patients have been neglected in COVID-19 trials: a call for action Trøseid, Marius Hentzien, Maxime Ader, Florence Cardoso, Sandra Wagner Arribas, Jose R. Molina, Jean-Michel Mueller, Nicolas Hites, Maya Bonnet, Fabrice Manuel, Oriol Costagliola, Dominique Grinsztejn, Beatriz Olsen, Inge Christoffer Yazdapanah, Yazdan Calmy, Alexandra Clin Microbiol Infect Commentary Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022-09 2022-05-25 /pmc/articles/PMC9130310/ /pubmed/35623577 http://dx.doi.org/10.1016/j.cmi.2022.05.005 Text en © 2022 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Trøseid, Marius Hentzien, Maxime Ader, Florence Cardoso, Sandra Wagner Arribas, Jose R. Molina, Jean-Michel Mueller, Nicolas Hites, Maya Bonnet, Fabrice Manuel, Oriol Costagliola, Dominique Grinsztejn, Beatriz Olsen, Inge Christoffer Yazdapanah, Yazdan Calmy, Alexandra Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title | Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title_full | Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title_fullStr | Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title_full_unstemmed | Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title_short | Immunocompromised patients have been neglected in COVID-19 trials: a call for action |
| title_sort | immunocompromised patients have been neglected in covid-19 trials: a call for action |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130310/ https://www.ncbi.nlm.nih.gov/pubmed/35623577 http://dx.doi.org/10.1016/j.cmi.2022.05.005 |
| work_keys_str_mv | AT trøseidmarius immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT hentzienmaxime immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT aderflorence immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT cardososandrawagner immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT arribasjoser immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT molinajeanmichel immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT muellernicolas immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT hitesmaya immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT bonnetfabrice immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT manueloriol immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT costaglioladominique immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT grinsztejnbeatriz immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT olseningechristoffer immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT yazdapanahyazdan immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT calmyalexandra immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction AT immunocompromisedpatientshavebeenneglectedincovid19trialsacallforaction |